Brigit Biofarmaka Teknologi Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 67.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 429.7K). Which is the better fit depends on your goals.
| OBAT | TSPC | |
|---|---|---|
Market Cap | 172.82B | 11.68T |
Volume | 592.2K | 429.7K |
Lot | 5.92K | 4.3K |
Turnover | 147.05M | 1.11B |
Average Price | 248.31 | 2,591.65 |
Value | 147.05M | 1.11B |
Indicative Equilibrium Price | 254 | 2,580 |
Indicative Equilibrium Volume | 10 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →